|
WWTR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.103360E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.21150000049242E-07 |
| Normal-vs-Stage2 |
5.565600E-01 |
| Normal-vs-Stage3 |
5.478400E-01 |
| Normal-vs-Stage4 |
9.448800E-01 |
| Stage1-vs-Stage2 |
3.690500E-02 |
| Stage1-vs-Stage3 |
3.957300E-03 |
| Stage1-vs-Stage4 |
1.943290E-03 |
| Stage2-vs-Stage3 |
9.238000E-01 |
| Stage2-vs-Stage4 |
5.977200E-01 |
| Stage3-vs-Stage4 |
6.184200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.421900E-04 |
| Normal-vs-AfricanAmerican |
8.216000E-01 |
| Normal-vs-Asian |
4.529200E-01 |
| Caucasian-vs-AfricanAmerican |
1.695950E-01 |
| Caucasian-vs-Asian |
8.042400E-01 |
| AfricanAmerican-vs-Asian |
4.650200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.085800E-02 |
| Normal-vs-Female |
5.81549999999487E-05 |
| Male-vs-Female |
5.118900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.317800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.042100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.108300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.495200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.782800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.930800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.129600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.516400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.617500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.817830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.900900E-03 |
| Normal-vs-Grade 2 |
2.21009999999966E-05 |
| Normal-vs-Grade 3 |
8.267600E-02 |
| Normal-vs-Grade 4 |
2.230000E-01 |
| Grade 1-vs-Grade 2 |
2.106400E-02 |
| Grade 1-vs-Grade 3 |
3.043900E-03 |
| Grade 1-vs-Grade 4 |
4.34590000000235E-05 |
| Grade 2-vs-Grade 3 |
3.725500E-02 |
| Grade 2-vs-Grade 4 |
1.757790E-04 |
| Grade 3-vs-Grade 4 |
3.013800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.26919952115179E-10 |
| Normal-vs-ccB subtype |
4.491400E-01 |
| ccA subtype-vs-ccB subtype |
3.71660000000329E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.383700E-03 |
| Normal-vs-N1 |
3.844400E-01 |
| N0-vs-N1 |
6.681400E-01 |
|
|
